Handelsbanken Fonder’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
19,300
+5,400
+39% +$581K 0.01% 751
2026
Q1
$1.42M Hold
13,900
﹤0.01% 881
2025
Q4
$1.4M Hold
13,900
﹤0.01% 895
2025
Q3
$1.2M Buy
13,900
+1,900
+16% +$150K ﹤0.01% 931
2025
Q2
$916K Buy
12,000
+1,200
+11% +$87.8K ﹤0.01% 1005
2025
Q1
$766K Hold
10,800
﹤0.01% 1056
2024
Q4
$845K Buy
10,800
+1,500
+16% +$140K ﹤0.01% 1042
2024
Q3
$951K Buy
9,300
+1,600
+21% +$133K ﹤0.01% 967
2024
Q2
$584K Buy
7,700
+2,300
+43% +$164K ﹤0.01% 1085
2024
Q1
$405K Hold
5,400
﹤0.01% 1258
2023
Q4
$397K Buy
+5,400
New +$334K ﹤0.01% 1253

Other funds holding NUVL

Handelsbanken Fonder's NUVL Position: Q2 2026 in Review

Handelsbanken Fonder increased its Nuvalent (NUVL) stake by 39% in Q2 2026, buying an estimated $581K and bringing the position to 19,300 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #751.

Handelsbanken Fonder first reported a position in NUVL in Q4 2023 and has held it in 11 quarters since. 52 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Handelsbanken Fonder held 19,300 shares of Nuvalent worth $2.38M as of Q2 2026.
  • Handelsbanken Fonder bought 5,400 Nuvalent shares in Q2 2026, an estimated $581K.
  • Nuvalent made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #751 holding.
  • Handelsbanken Fonder first reported a position in Nuvalent in Q4 2023 and has held it in 11 quarters since.
  • 52 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.